TY  - GEN
AU  - Perry,James R
AU  - Laperriere,Normand
AU  - O'Callaghan,Christopher J
AU  - Brandes,Alba A
AU  - Menten,Johan
AU  - Phillips,Claire
AU  - Fay,Michael
AU  - Nishikawa,Ryo
AU  - Cairncross,J Gregory
AU  - Roa,Wilson
AU  - Osoba,David
AU  - Rossiter,John P
AU  - Sahgal,Arjun
AU  - Hirte,Hal
AU  - Laigle-Donadey,Florence
AU  - Franceschi,Enrico
AU  - Chinot,Olivier
AU  - Golfinopoulos,Vassilis
AU  - Fariselli,Laura
AU  - Wick,Antje
AU  - Feuvret,Loic
AU  - Back,Michael
AU  - Tills,Michael
AU  - Winch,Chad
AU  - Baumert,Brigitta G
AU  - Wick,Wolfgang
AU  - Ding,Keyue
AU  - Mason,Warren P
TI  - Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
SN  - 1533-4406
PY  - 2017///0424
KW  - Aged
KW  - Aged, 80 and over
KW  - Central Nervous System Neoplasms
KW  - drug therapy
KW  - Chemoradiotherapy
KW  - Dacarbazine
KW  - adverse effects
KW  - Disease Progression
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Male
KW  - Quality of Life
KW  - Radiotherapy
KW  - methods
KW  - Survival Analysis
KW  - Temozolomide
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1611977
ER  -